Forgot Password.
By Logging in, you are agreeing to the MedSearch Global Terms of Use and Privacy Policy.
Not a member? Sign Up
By Signing up, you are agreeing to the MedSearch Global Terms of Use and Privacy Policy.
Have an account? Log in
Back to Login? Log in
By registering in, you are agreeing to the MedSearch Global terms and condition and Privacy Policy.
Thinking of joining a study?
Register your interest
363 results
Interventional
Not Applicable
126
Phoenix Thera-Lase System
SHAM Phoenix Thera-Lase System
David Moss
Source: clinicaltrials.gov
Phase3
250
ZILRETTA
TCA-IR
Placebo
Pacira Pharmaceuticals, Inc
60
KneeBRIGHT System
Control Exercise
Barron Associates, Inc.
Phase2
50
Tranexamic Acid
Placebos
Stanford University
924
targeted synthetic DMARD class
non-TNFi-biologic class
University of Alabama at Birmingham
Phase1
30
Etanercept Optimal dosing
Duke University
300
DoD/VA CPG Core Set + PT
DoD/VA CPG Core Set
Brooke Army Medical Center
36
Mesenchymal Stromal Cells (MSC) Dose Level 0
Mesenchymal Stromal Cells (MSC) Dose Level 1
University of Wisconsin, Madison
Phase4
195
Voltaren Gel 1% (diclofenac sodium) (US only)
Voltaren Gel 1.16% (diclofenac diethylammonium) (EU only)
Voltaren Gel 2.32% (diclofenac diethylammonium) (EU only)
HALEON
35
Butyrate
NYU Langone Health